|
JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
GR75598B
(US07829113-20101109-C00013.png)
|
1980-04-29 |
1984-08-01 |
Sanofi Sa |
|
|
US4534899A
(en)
*
|
1981-07-20 |
1985-08-13 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
|
US4565696A
(en)
*
|
1983-08-03 |
1986-01-21 |
The Regents Of The University Of California |
Production of immunogens by antigen conjugation to liposomes
|
|
US4925661A
(en)
*
|
1984-04-19 |
1990-05-15 |
Leaf Huang |
Target-specific cytotoxic liposomes
|
|
US4789633A
(en)
|
1984-04-19 |
1988-12-06 |
University Of Tennessee Research Corporation |
Fused liposome and acid induced method for liposome fusion
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
EP0211042A1
(en)
*
|
1985-01-18 |
1987-02-25 |
Cooper-Lipotech, Inc. |
Liposome composition and method
|
|
US4762915A
(en)
*
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US5026651A
(en)
*
|
1985-04-25 |
1991-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the production of human transferrin
|
|
PH26160A
(en)
*
|
1985-08-19 |
1992-03-18 |
Univ Texas |
Pharmaceutical compositions consisting of acylated phospholipids
|
|
US4983397A
(en)
*
|
1985-08-19 |
1991-01-08 |
Board Of Regents, University Of Texas System |
Pharmaceutical compositions consisting of acylated phospholipids
|
|
US5384127A
(en)
*
|
1985-10-18 |
1995-01-24 |
Board Of Regents, The University Of Texas System |
Stable liposomal formulations of lipophilic platinum compounds
|
|
JPH0714865B2
(ja)
*
|
1986-10-28 |
1995-02-22 |
武田薬品工業株式会社 |
リポソ−ム製剤およびその製造法
|
|
US5049390A
(en)
*
|
1987-09-02 |
1991-09-17 |
Allergy Immuno Technologies, Inc. |
Liposome containing immunotherapy agents for treating IgE mediated allergies
|
|
US4853224A
(en)
|
1987-12-22 |
1989-08-01 |
Visionex |
Biodegradable ocular implants
|
|
FR2631826B1
(fr)
*
|
1988-05-27 |
1992-06-19 |
Centre Nat Rech Scient |
Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
|
|
JPH0720857B2
(ja)
*
|
1988-08-11 |
1995-03-08 |
テルモ株式会社 |
リポソームおよびその製法
|
|
ATE233100T1
(de)
*
|
1989-08-02 |
2003-03-15 |
Mitra Medical Technology Ab |
System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
CA2093665A1
(en)
*
|
1990-10-09 |
1992-04-10 |
Sean M. Sullivan |
Phospholipid analogue vesicle
|
|
US5554728A
(en)
*
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
|
US6509032B1
(en)
|
1991-08-28 |
2003-01-21 |
Mcmaster University |
Cationic amphiphiles
|
|
US5292524A
(en)
*
|
1991-09-06 |
1994-03-08 |
California Institute Of Technology |
Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus
|
|
JPH0776230B2
(ja)
*
|
1992-01-13 |
1995-08-16 |
田中貴金属工業株式会社 |
白金化合物の製造方法
|
|
JPH06287021A
(ja)
*
|
1992-04-22 |
1994-10-11 |
Tanaka Kikinzoku Kogyo Kk |
光学活性な白金錯化合物の光学的分割方法
|
|
JP2673331B2
(ja)
*
|
1993-01-12 |
1997-11-05 |
田中貴金属工業 株式会社 |
光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
|
|
US20030190638A1
(en)
|
1992-05-13 |
2003-10-09 |
Board Of Regents, The University Of Texas System |
Methods of screening for compounds that derepress or increase telomerase activity
|
|
US20030100489A1
(en)
*
|
1992-10-16 |
2003-05-29 |
Beach David H. |
Cell-cycle regulatory proteins, and uses related thereto
|
|
US5962316A
(en)
*
|
1992-10-16 |
1999-10-05 |
Cold Spring Harbor Laboratory |
Cell-cycle regulatory proteins, and uses related thereto
|
|
AU6833994A
(en)
|
1993-05-17 |
1994-12-12 |
Liposome Company, Inc., The |
Incorporation of taxol into liposomes and gels
|
|
JP3025602B2
(ja)
*
|
1993-05-21 |
2000-03-27 |
デビオファーム エス．アー． |
光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
|
|
US5534241A
(en)
*
|
1993-07-23 |
1996-07-09 |
Torchilin; Vladimir P. |
Amphipathic polychelating compounds and methods of use
|
|
CA2150939C
(en)
*
|
1993-10-06 |
2001-05-01 |
David Collins |
Stable protein: phospholipid compositions and methods
|
|
WO1995016774A1
(en)
*
|
1993-12-17 |
1995-06-22 |
Spinal Cord Society |
Method for inducing dna synthesis in neurons
|
|
US6057299A
(en)
*
|
1994-01-13 |
2000-05-02 |
Calydon, Inc. |
Tissue-specific enhancer active in prostate
|
|
US5830686A
(en)
|
1994-01-13 |
1998-11-03 |
Calydon |
Tissue-specific enhancer active in prostate
|
|
JP3590983B2
(ja)
*
|
1994-03-04 |
2004-11-17 |
日本油脂株式会社 |
リン脂質誘導体
|
|
CA2185810A1
(en)
|
1994-03-28 |
1995-10-05 |
Jo Klaveness |
Liposomes
|
|
PT773921E
(pt)
|
1994-07-29 |
2000-05-31 |
Abbott Lab |
Processo para a preparacao de um 2,5-diamino-2-hidroxi-hexano substituido
|
|
UA42779C2
(uk)
|
1994-08-08 |
2001-11-15 |
Дебіофарм С.А. |
Фармацевтично стійкий препарат оксалату платини для парентерального застосування
|
|
ATE198419T1
(de)
*
|
1994-10-14 |
2001-01-15 |
Liposome Co Inc |
Etherlipid-liposomen und deren therapeutische verwendung
|
|
DE69531722T2
(de)
|
1994-11-11 |
2004-07-01 |
Debiopharm S.A. |
Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
|
|
US5786214A
(en)
*
|
1994-12-15 |
1998-07-28 |
Spinal Cord Society |
pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
|
|
US5580899A
(en)
*
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
TW319763B
(US07829113-20101109-C00013.png)
|
1995-02-01 |
1997-11-11 |
Epix Medical Inc |
|
|
US5780052A
(en)
*
|
1995-04-24 |
1998-07-14 |
Northeastern University |
Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell
|
|
US5834012A
(en)
*
|
1995-05-03 |
1998-11-10 |
Roman Perez-Soler |
Lipid complexed topoisomerase I inhibitors
|
|
US20020022264A1
(en)
|
1995-05-26 |
2002-02-21 |
Sullivan Sean M. |
Delivery vehicles comprising stable lipid/nucleic acid complexes
|
|
US6825174B2
(en)
*
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
JPH09278785A
(ja)
|
1996-04-10 |
1997-10-28 |
Tanaka Kikinzoku Kogyo Kk |
白金化合物の製造方法
|
|
FR2740686B1
(fr)
|
1995-11-03 |
1998-01-16 |
Sanofi Sa |
Formulation pharmaceutique lyophilisee stable
|
|
US6428977B1
(en)
|
1995-12-20 |
2002-08-06 |
Curis, Inc. |
Signalin family of TGFβ signal transduction proteins, and uses related thereto
|
|
JP3735921B2
(ja)
*
|
1996-02-07 |
2006-01-18 |
三菱ウェルファーマ株式会社 |
ＧＰＩｂ・脂質複合体およびその用途
|
|
WO1997028817A1
(en)
*
|
1996-02-09 |
1997-08-14 |
Cheng Pi Wan |
Receptor ligand-facilitated delivery of biologically active molecules
|
|
US6153646A
(en)
|
1996-03-11 |
2000-11-28 |
Yoshinori Kidani |
Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes
|
|
US6197333B1
(en)
*
|
1996-03-28 |
2001-03-06 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved liposome compositions
|
|
JP3154399B2
(ja)
|
1996-07-04 |
2001-04-09 |
デビオファーム エス．アー． |
白金化合物の製造方法
|
|
US6228391B1
(en)
*
|
1996-05-02 |
2001-05-08 |
Terumo Kabushiki Kaisha |
Amidine derivatives and drug carriers comprising the same
|
|
WO1998007409A1
(en)
|
1996-08-23 |
1998-02-26 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
|
US6056973A
(en)
*
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
TW520297B
(en)
*
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
|
AU725257B2
(en)
|
1996-10-15 |
2000-10-12 |
Transave, Inc. |
N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
|
|
DK0964690T3
(da)
*
|
1996-10-15 |
2003-10-20 |
Liposome Co Inc |
Peptid-lipidkonjugater, liposomer og liposomal lægemiddeladministration
|
|
US6153596A
(en)
|
1996-12-18 |
2000-11-28 |
Emory University |
Polycationic oligomers
|
|
CA2281807C
(en)
|
1997-03-07 |
2007-10-16 |
Sanofi Pharmaceuticals, Inc. |
Method of treating a tumor
|
|
JPH10253632A
(ja)
*
|
1997-03-10 |
1998-09-25 |
Nissui Pharm Co Ltd |
分析方法、キット及び装置
|
|
DE19709704C2
(de)
*
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US6120751A
(en)
*
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US6524613B1
(en)
*
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
|
US6272370B1
(en)
*
|
1998-08-07 |
2001-08-07 |
The Regents Of University Of Minnesota |
MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging
|
|
AU7984498A
(en)
|
1997-06-25 |
1999-01-04 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Serum-free cell growth medium
|
|
EP1007564A4
(en)
*
|
1997-07-15 |
2002-09-18 |
Univ California |
ISOLATED DNA ENCODING A HUMAN POTASSIUM-ACTIVATED POTASSIUM CHANNEL
|
|
DE69838584T2
(de)
|
1997-08-04 |
2008-06-26 |
Cell Genesys, Inc., Foster City |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
|
EP1019094B1
(en)
*
|
1997-10-02 |
2003-11-19 |
Epix Medical, Inc. |
Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
|
|
US6749863B1
(en)
*
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
US6320017B1
(en)
*
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
|
US6573101B1
(en)
*
|
1998-02-12 |
2003-06-03 |
The Regents Of The University Of California |
Compositions for receptor/liposome mediated transfection and methods of using same
|
|
GB9804013D0
(en)
|
1998-02-25 |
1998-04-22 |
Sanofi Sa |
Formulations
|
|
US6245427B1
(en)
*
|
1998-07-06 |
2001-06-12 |
DüZGüNES NEJAT |
Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
|
|
BRPI9914508B8
(pt)
*
|
1998-10-14 |
2021-05-25 |
Debiopharm Sa |
bolsa flexível impermeável para uso médico contendo uma preparação farmacêutica de oxaliplatina sob a forma líquida
|
|
US7311924B2
(en)
*
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
US6723338B1
(en)
*
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
|
WO2000069915A2
(en)
|
1999-05-17 |
2000-11-23 |
Avi Biopharma, Inc. |
COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
|
|
JP2001002592A
(ja)
|
1999-06-18 |
2001-01-09 |
Dai Ichi Seiyaku Co Ltd |
遺伝子導入用組成物
|
|
US6280054B1
(en)
*
|
1999-07-02 |
2001-08-28 |
Zight Corporation |
Image generator having an improved illumination system
|
|
US6242188B1
(en)
*
|
1999-07-30 |
2001-06-05 |
Applied Gene Technologies, Inc. |
Sample processing to release nucleic acids for direct detection
|
|
EP1204241A1
(en)
*
|
1999-08-09 |
2002-05-08 |
Fujitsu Limited |
Package control device and method
|
|
CA2382389C
(fr)
|
1999-08-30 |
2010-06-29 |
Debiopharm S.A. |
Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
|
|
AU3366901A
(en)
|
1999-12-30 |
2001-07-16 |
Novartis Ag |
Novel colloid synthetic vectors for gene therapy
|
|
BR0016864A
(pt)
|
1999-12-30 |
2002-09-24 |
Judith K Gwathmey |
Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento
|
|
US7034006B2
(en)
*
|
2000-01-10 |
2006-04-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of disease
|
|
US6530944B2
(en)
*
|
2000-02-08 |
2003-03-11 |
Rice University |
Optically-active nanoparticles for use in therapeutic and diagnostic methods
|
|
US7001735B2
(en)
*
|
2000-03-01 |
2006-02-21 |
Albert Einstein College Of Medicine Of Yeshiva University |
Glucose transporter/sensor protein and uses thereof
|
|
ATE374785T1
(de)
*
|
2000-03-02 |
2007-10-15 |
Mitsubishi Pharma Corp |
Gpib-gebundenes konstrukt und verwendungen davon
|
|
JP4449147B2
(ja)
|
2000-03-22 |
2010-04-14 |
日油株式会社 |
ホスファチジルエタノールアミン誘導体の製造方法
|
|
FR2806727A1
(fr)
|
2000-03-23 |
2001-09-28 |
Pf Medicament |
Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
|
|
ATE382333T1
(de)
|
2000-04-12 |
2008-01-15 |
Liplasome Pharma As |
Auf lipiden basierende arzneistoffabgabesysteme gegen parasitäre infektionen
|
|
CZ20023913A3
(cs)
*
|
2000-05-03 |
2003-09-17 |
Munich Biotech Ag |
Kationtová diagnostická, zobrazovací a terapeutická činidla spojená s aktivovanými cévními místy
|
|
US20030059461A1
(en)
*
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
|
US20030072794A1
(en)
*
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
CA2421872A1
(en)
*
|
2000-09-11 |
2002-03-14 |
Institut Pasteur |
Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant
|
|
US20040234588A1
(en)
|
2000-09-21 |
2004-11-25 |
University Of Georgia Research Foundation, Inc. |
Artificial lipoprotein carrier system for bioactive materials
|
|
US20040126431A1
(en)
*
|
2000-10-03 |
2004-07-01 |
Frederic Lagarce |
Method for preparing microspheres containing a water-soluble substance
|
|
US20030129223A1
(en)
*
|
2000-10-11 |
2003-07-10 |
Targesome, Inc. |
Targeted multivalent macromolecules
|
|
WO2002041870A2
(en)
|
2000-11-22 |
2002-05-30 |
Vectron Therapeutics Ag |
Production and use of a targeted diagnostic system
|
|
CN1559007A
(zh)
*
|
2000-12-12 |
2004-12-29 |
澳大利亚海洋科学研究院 |
致瘫痪水生有壳类动物毒素的分析
|
|
WO2002047725A2
(fr)
*
|
2000-12-12 |
2002-06-20 |
Debiopharm S.A. |
Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
|
|
US6897196B1
(en)
*
|
2001-02-07 |
2005-05-24 |
The Regents Of The University Of California |
pH sensitive lipids based on ortho ester linkers, composition and method
|
|
US6703524B2
(en)
*
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
|
EP1368022B1
(fr)
|
2001-03-02 |
2007-06-20 |
Debiopharm S.A. |
Utilisation d'un flacon contenant une solution d'oxaliplatine
|
|
FI113840B
(fi)
|
2001-03-26 |
2004-06-30 |
Ctt Cancer Targeting Tech Oy |
Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
|
|
US20040049022A1
(en)
*
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
CA2445947A1
(en)
|
2001-04-30 |
2002-11-07 |
Targeted Genetics Corporation |
Lipid-comprising drug delivery complexes and methods for their production
|
|
WO2002089772A1
(en)
*
|
2001-05-09 |
2002-11-14 |
Inex Pharmaceuticals Corporation |
Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents
|
|
US20030108986A1
(en)
*
|
2001-06-21 |
2003-06-12 |
Euroscreen, S.A. |
Compositions and methods comprising G-protein coupled receptors
|
|
WO2003004505A1
(en)
|
2001-07-02 |
2003-01-16 |
Debiopharm S.A. |
Oxaliplatin active substance with a very low content of oxalic acid
|
|
US20030096299A1
(en)
*
|
2001-07-09 |
2003-05-22 |
Valerie Wittamer |
Natural ligand of G protein coupled receptor ChemR23 and uses thereof
|
|
US6793912B2
(en)
*
|
2001-08-20 |
2004-09-21 |
Transave Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
DE10144252A1
(de)
|
2001-08-31 |
2003-03-27 |
Fraunhofer Ges Forschung |
Nanopartikel mit daran immobilisiertem biologisch aktivem TNF
|
|
AU2002330139A1
(en)
*
|
2001-10-03 |
2003-04-14 |
Vanderbilt University |
In vivo panning for ligands to radiation-induced molecules
|
|
US7101985B2
(en)
|
2001-11-20 |
2006-09-05 |
Baylor College Of Medicine |
Methods and compositions in checkpoint signaling
|
|
JP4468617B2
(ja)
|
2001-12-04 |
2010-05-26 |
デビオファーム エス．アー． |
抗癌剤の併用投与方法及び併用可能な抗癌剤
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
JP4360915B2
(ja)
|
2002-01-07 |
2009-11-11 |
ユーロスクリーン・ソシエテ・アノニム |
Ｇタンパク質共役受容体ｇｐｒ４３のリガンドおよびその使用
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
ATE477276T1
(de)
*
|
2002-03-01 |
2010-08-15 |
Immunomedics Inc |
Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen
|
|
WO2004065621A1
(en)
*
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
WO2003082907A1
(en)
|
2002-03-29 |
2003-10-09 |
Euroscreen Sa |
Ligands for g protein coupled receptor gpr7 and uses thereof
|
|
CA2391438A1
(en)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Psp94 diagnostic reagents and assays
|
|
US20030228285A1
(en)
|
2002-05-03 |
2003-12-11 |
Mien-Chie Hung |
Bipartite T-cell factor (Tcf)-responsive promoter
|
|
US7460960B2
(en)
|
2002-05-10 |
2008-12-02 |
Epitome Biosystems, Inc. |
Proteome epitope tags and methods of use thereof in protein modification analysis
|
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
FR2840236B1
(fr)
|
2002-06-03 |
2005-02-04 |
Inst Francais Du Petrole |
Membrane zeolithique de faible epaisseur, sa preparation et son utilisation en separation
|
|
JP3415131B1
(ja)
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
CA2488753A1
(en)
*
|
2002-06-07 |
2003-12-18 |
Immunomedics, Inc. |
Neutrophil imaging methods in cyctic fibrosis
|
|
CA2489467C
(en)
*
|
2002-06-14 |
2015-02-24 |
Immunomedics, Inc. |
Humanized monoclonal antibody hpam4
|
|
WO2003106497A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Immunomedics, Inc. |
Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
|
|
US6790632B2
(en)
|
2002-06-17 |
2004-09-14 |
Stephen Eliot Zweig |
Membrane receptor reagent and assay
|
|
DK1519714T3
(da)
*
|
2002-06-28 |
2011-01-31 |
Protiva Biotherapeutics Inc |
Fremgangsmåde og apparat til fremstilling af liposomer
|
|
AU2003248982B2
(en)
|
2002-08-01 |
2009-12-10 |
Immunomedics, Inc. |
Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
|
|
US20040132652A1
(en)
*
|
2002-08-30 |
2004-07-08 |
Shire Biochem Inc. |
Pharmaceutical compositions
|
|
WO2004045519A2
(en)
|
2002-11-14 |
2004-06-03 |
Kirk Sperber |
Induction of apoptosis by hiv-1 infected monocytic cells
|
|
WO2004045583A1
(ja)
|
2002-11-15 |
2004-06-03 |
Nipro Corporation |
リポソーム
|
|
MXPA05008687A
(es)
|
2003-02-17 |
2005-10-05 |
Mebiopharm Co Ltd |
Remedio para cancer.
|
|
AU2004232928A1
(en)
*
|
2003-04-22 |
2004-11-04 |
Ibc Pharmaceuticals |
Polyvalent protein complex
|
|
US7172751B2
(en)
*
|
2003-06-13 |
2007-02-06 |
Immunomedics, Inc. |
D-amino acid peptides
|
|
WO2005012493A2
(en)
*
|
2003-07-31 |
2005-02-10 |
Immunomedics, Inc. |
Anti-cd19 antibodies
|
|
JP2005154282A
(ja)
|
2003-11-20 |
2005-06-16 |
Mebiopharm Co Ltd |
ガス封入リポソームの製造法
|
|
US7582430B2
(en)
*
|
2004-01-20 |
2009-09-01 |
United States Of America As Represented By The Secretary Of The Army |
Immunoliposome-nucleic acid amplification (ILNAA) assay
|
|
US7212869B2
(en)
*
|
2004-02-04 |
2007-05-01 |
Medtronic, Inc. |
Lead retention means
|
|
EP1579850A3
(en)
|
2004-03-15 |
2009-12-16 |
Nipro Corporation |
A pharmaceutical composition containing liposomes for treating a cancer
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
WO2008030818A2
(en)
|
2006-09-05 |
2008-03-13 |
Mebiopharm Co., Ltd. |
Novel liposome compositions
|
|
JP5345792B2
(ja)
|
2008-02-19 |
2013-11-20 |
テイ・エス テック株式会社 |
車両用格納シート
|
|
JP5331648B2
(ja)
|
2009-10-22 |
2013-10-30 |
株式会社日立製作所 |
微粉炭ボイラの改造方法
|
